Park S H, Schatz R A
Toxicology Program, Northeastern University, Boston, Massachusetts 02115, USA.
J Toxicol Environ Health A. 1999 Nov 12;58(5):299-312. doi: 10.1080/009841099157269.
o-Xylene is a commonly used solvent that alters mixed-function oxidase (MFO) activity in an organ- and isozyme-specific pattern following intraperitoneal (ip) administration. Similar MFO alterations have been observed after ip or inhalation exposure to other methyl benzenes. These MFO alterations shifted the metabolism of the carcinogen benzo[a]pyrene (BaP) toward formation of toxication metabolites in lung. The purpose of this study was to determine whether o-xylene inhalation caused similar MFO changes and whether these alterations were reflected in altered BaP metabolism and BaP-DNA adduct formation. o-Xylene (300 ppm, 6 h) decreased the activity of arylhydrocarbon hydroxylase (AHH) in lung. CYP2B1 activity (benzyloxyresorufin O-dealkylase; BROD), which is responsible for metabolism of BaP to relatively nontoxic metabolites, was decreased in lung, as was, to a lesser extent, CYP1A1 (ethoxyresorufin O-dealkylase; EROD), which is responsible for metabolism of BaP to reactive/toxic metabolites. The BROD/EROD ratio, an indirect indicator of the pattern of BaP toxication/detoxication, was decreased in lung, suggesting that BaP metabolism is shifted toward toxication. No MFO alterations were observed in liver. In lung microsomes, o-xylene increased formation of 7,8-BaP-diol, while 9,10-BaP-diol, 3-OH BaP, and 9-OH BaP were decreased. In liver, o-xylene increased 9-OH BaP formation, while 4,5- and 9,10-diols as well as total diols were decreased. The toxication/detoxication ratios for BaP individual and total metabolite groups were increased in lung microsomes and unaltered in liver. The major BaP-DNA adduct, BaP diol epoxide-N2-deoxyguanosine, was increased in lung but decreased in liver microsomes from o-xylene-exposed rats. Four minor BaP-DNA adducts were formed in lung and three in liver, only one of which (liver adduct 3) was decreased. The o-xylene-induced increase in BaP adduct formation in lung and decrease in liver indicate that coexposure to organic solvents such as the methyl benzenes may alter the carcinogenesis of BaP, or other PAHs, in an organ-specific fashion.
邻二甲苯是一种常用溶剂,腹腔注射后会以器官和同工酶特异性模式改变混合功能氧化酶(MFO)的活性。腹腔注射或吸入接触其他甲基苯后也观察到了类似的MFO改变。这些MFO改变使致癌物苯并[a]芘(BaP)的代谢向肺中形成毒性代谢物的方向转变。本研究的目的是确定吸入邻二甲苯是否会引起类似的MFO变化,以及这些变化是否反映在BaP代谢改变和BaP-DNA加合物形成上。邻二甲苯(300 ppm,6小时)降低了肺中芳烃羟化酶(AHH)的活性。负责将BaP代谢为相对无毒代谢物的CYP2B1活性(苄氧基试卤灵O-脱烷基酶;BROD)在肺中降低,负责将BaP代谢为反应性/毒性代谢物的CYP1A1(乙氧基试卤灵O-脱烷基酶;EROD)在较小程度上也降低。BROD/EROD比值是BaP毒性/解毒模式的间接指标,在肺中降低,表明BaP代谢向毒性方向转变。在肝脏中未观察到MFO改变。在肺微粒体中,邻二甲苯增加了7,8-BaP-二醇的形成,而9,10-BaP-二醇、3-OH BaP和9-OH BaP减少。在肝脏中,邻二甲苯增加了9-OH BaP的形成,但4,5-二醇和9,10-二醇以及总二醇减少。肺微粒体中BaP个体和总代谢物组的毒性/解毒比值增加,而肝脏中未改变。主要的BaP-DNA加合物,BaP二醇环氧化物-N2-脱氧鸟苷,在暴露于邻二甲苯的大鼠的肺中增加,但在肝脏微粒体中减少。在肺中形成了四种次要的BaP-DNA加合物,在肝脏中形成了三种,其中只有一种(肝脏加合物3)减少。邻二甲苯诱导的肺中BaP加合物形成增加和肝脏中减少表明,同时接触有机溶剂如甲基苯可能以器官特异性方式改变BaP或其他多环芳烃的致癌作用。